Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06245382 · ClinicalTrials.gov registry record · NA
The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive Health
A NA study, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT06245382: Completed NA study, sponsored by The University of Texas at Arlington.
NCT06245382 is a NA study that has completed, run by The University of Texas at Arlington. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06245382, a NA study, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The overall research objective of this proposal is to determine the acute and chronic impact of daily supplementation of a Good Health beverage on indices of physiological and neurocognitive health.
Primary Outcome
Flow medicated dilation of the brachial artery
Interventions
- DIETARY_SUPPLEMENT Goode Health Beverage
- DIETARY_SUPPLEMENT Vanilla Base Beverage Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT06245382 record still lists
NCT06245382 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Goode Health Beverage is the first listed.
NCT06245382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06245382 about?
NCT06245382 is a clinical study titled "The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive Health". The overall research objective of this proposal is to determine the acute and chronic impact of daily supplementation of a Good Health beverage on indices of physiological and neurocognitive health.
What is the current status of trial NCT06245382?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2023-10-01. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06245382?
The interventions under investigation include: Goode Health Beverage (DIETARY_SUPPLEMENT), Vanilla Base Beverage Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06245382?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06245382's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI